CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it will host a live webcast to present and discuss the newly disclosed, late-breaking 48-week Phase 3 clinical data in China for...

People

6 Energy-Saving Tips

SkinBliss Skin Tag Remover Under Review: The Super Luxe Skin Tag...

The Honest Company Reports First Quarter 2025 Results

Alto Ingredients, Inc. Reports First Quarter 2025 Results

The Honest Company Announces Appointment of Curtiss Bruce as Chief Financial...

Best Fortune Teller Online For Accurate Fortune Telling In 2025 –...

K&D Locksmith NYC Announce 24 Hour Emergency Locksmith Services

Pacific Prime Issues Report on the Leading Providers in the Philippines...

VistaJet and Dr. Barbara Sturm Unveil Exclusive Global Partnership

Honka’s unique interior styles blend perfectly with modern log home structures

Prime Biome Reviews Fixed What Doctors Couldn’t – In Just Weeks!...

Featured

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...

6 Energy-Saving Tips

Saudia Unveils SV Lifestyle Brand at Riyadh Fashion Week

All Star Digital and Dart Co Launch One Hitters: Exclusive Partnership...

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...